Vanguard Group Inc Re Shape Lifesciences Inc. Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.32 - $15.6 $123,202 - $6.01 Million	-385,008 Reduced 76.45%	118,607 $36,000
Q4 2021 Feb 14, 2022	BUY	$1.64 - $3.13 $735,111 - $1.4 Million	448,239 Added 809.45%	503,615 $826,000
Q3 2021 Nov 12, 2021	BUY	$2.67 - $5.09 $11,363 - $21,663	4,256 Added 8.33%	55,376 $159,000
Q2 2021 Aug 13, 2021	BUY	$2.02 - $7.64 $103,262 - $390,556	51,120 New	51,120 $256,000

Ticker RSLS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,559,400
Market Cap $130M
Description
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical sta...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.